HDAC9 and cancer: The small-molecule DNA methylation inhibitor AZA or HDAC inhibitor TSA have been shown to effectively reverse gene repression, and this combination appears to influence pathways in cancer and apoptosis (Supplementary Figures S2 and S3) [27–29].